UnitedHealth Group (UNH) Q2 2025 earnings summary

Executive summary

• Q2 2025 revenues reached $111.6 billion, up 13% year-over-year, driven by UnitedHealthcare and Optum growth, but earnings from operations fell to $5.2 billion from $7.9 billion due to elevated medical cost trends.

• Leadership emphasized transparency, operational discipline, and cultural reform, implementing extensive management and operational changes to address financial and operational challenges.

• UnitedHealthcare added up to 1.0 million members, mainly in Medicare Advantage and commercial offerings.

• Adjusted EPS for Q2 2025 was $4.08, reflecting $1.2 billion in unfavorable discrete impacts.

• Full-year 2025 revenue outlook is $445.5–$448.0 billion, with adjusted EPS of at least $16.00.

Financial highlights

• Q2 2025 revenues were $111.6 billion, up 13% from $98.9 billion in Q2 2024.

• Net earnings attributable to shareholders for Q2 2025 were $3.4 billion, down from $4.2 billion in Q2 2024.

• Adjusted net earnings for Q2 2025 were $3.7 billion, with adjusted EPS of $4.08.

• Operating margin for Q2 2025 was 4.6%, down from 8.0% in Q2 2024.

• Cash flows from operations for the first half of 2025 were $12.6 billion; Q2 2025 cash flows from operations were $7.2 billion.

Outlook and guidance

• Full-year 2025 revenues expected between $445.5 billion and $448.0 billion, with adjusted EPS at least $16.00 and medical care ratio at 89.25%.

• 2025 outlook reflects $6.5 billion in higher-than-expected medical costs, mainly in Medicare and commercial segments.

• 2026 pricing strategies focus on margin recovery, with Medicare Advantage trend assumptions raised to 10% and significant benefit adjustments and plan exits planned.

• Earnings growth is expected to be moderate in 2026, with a stronger rebound anticipated in 2027 and beyond.

• Tax rate for 2025 is estimated at 18.5%.